AtriCure, Inc. (ATRC)

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

The chart shows the growth of an initial investment of $10,000 in AtriCure, Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.

AtriCure, Inc. (ATRC) has returned -27.88% so far this year and -11.56% over the past 12 months. Over the last ten years, ATRC has returned 5.45% per year, falling short of the S&P 500 Index benchmark, which averaged 12.16% annually.

Based on dividend-adjusted daily data since Aug 5, 2005, ATRC's average daily return is +0.07%, while the average monthly return is +1.35%. At this rate, your investment would double in approximately 4.3 years.

Historically, 56% of months were positive and 44% were negative. The best month was May 2009 with a return of +98.4%, while the worst month was Nov 2008 at -61.5%. The longest winning streak lasted 8 consecutive months, and the longest losing streak was 8 months.

On a daily basis, ATRC closed higher 50% of trading days. The best single day was May 5, 2009 with a return of +125.7%, while the worst single day was Nov 3, 2008 at -39.4%.

AtriCure, Inc. has an annualized alpha of 11.36%, beta of 0.78, and R² of 0.07 versus S&P 500 Index. Calculated based on daily prices since August 08, 2005.

• This stock participated in 136.14% of S&P 500 Index downside but only 118.72% of its upside — more exposed to losses than it benefited from rallies.
• R² of 0.07 means this stock moves largely independently of S&P 500 Index — capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

ATRC ranks 29 for risk / return — below 29% of stocks on our site. The returns aren't fully compensating for the risk involved. This isn't necessarily a dealbreaker, but factor it into your decision — especially if you're risk-averse.

The table below present risk-adjusted performance metrics for AtriCure, Inc. (ATRC) and compare them to a chosen benchmark (S&P 500 Index).

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.

The table below displays the maximum drawdowns of the AtriCure, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the AtriCure, Inc. was 92.84%, occurring on Apr 24, 2009. Recovery took 1149 trading sessions.

The current AtriCure, Inc. drawdown is 67.26%.

The chart below shows the rolling one-month volatility.

The chart below illustrates the trends in the financial health of AtriCure, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

The Valuation section provides an overview of how AtriCure, Inc. is priced in the market compared to other companies in the Medical Instruments & Supplies industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.